| |
| |
| |
| |
| |
| | | | |
|
PR:P51587 |
breast cancer type 2 susceptibility protein (human) | | | | | |
| | | | | |
|
PR:000078580 |
breast cancer type 2 susceptibility protein cysteinylated 1 (human) | | | | | |
| | | | | |
|
PR:000066432 |
breast cancer type 2 susceptibility protein deaminated 1 (human) | | | | | |
| | | | | |
|
PR:000066492 |
breast cancer type 2 susceptibility protein deaminated 2 (human) | | | | | |
| | | | | |
|
PR:000072027 |
breast cancer type 2 susceptibility protein deaminated 3 (human) | | | | | |
| | | | | |
|
PR:000073005 |
breast cancer type 2 susceptibility protein deaminated 4 (human) | | | | | |
| | | | | |
|
PR:000067955 |
breast cancer type 2 susceptibility protein methylated 1 (human) | | | | | |
| | | | | |
|
PR:000070934 |
breast cancer type 2 susceptibility protein methylated 2 (human) | | | | | |
| | | | | |
|
PR:000072752 |
breast cancer type 2 susceptibility protein methylated 3 (human) | | | | | |
| | | | | |
|
PR:000080574 |
breast cancer type 2 susceptibility protein methylated 4 (human) | | | | | |
| | | | | |
|
PR:000035486 |
breast cancer type 2 susceptibility protein phosphorylated 1 (human) | | | | | |
| | | | | |
|
PR:000045544 |
breast cancer type 2 susceptibility protein phosphorylated 2 (human) | | | | | |
| | | | | |
|
PR:000045817 |
breast cancer type 2 susceptibility protein phosphorylated 3 (human) | | | | | |
| | | | | |
|
PR:000075561 |
breast cancer type 2 susceptibility protein phosphorylated 4 (human) | | | | | |
| | | | | |
|
PR:000061485 |
breast cancer type 2 susceptibility protein sequence variant C1200* (human) | | | | | |
| | | | | |
|
PR:000060791 |
breast cancer type 2 susceptibility protein sequence variant C2422* (human) | | | | | |
| | | | | |
|
PR:000060763 |
breast cancer type 2 susceptibility protein sequence variant C711* (human) | | | | | |
| | | | | |
|
PR:000064582 |
breast cancer type 2 susceptibility protein sequence variant D2723G (human) | | | | | |
| | | | | |
|
PR:000062322 |
breast cancer type 2 susceptibility protein sequence variant D2723H (human) | | | | | |
| | | | | |
|
PR:000063423 |
breast cancer type 2 susceptibility protein sequence variant E1113* (human) | | | | | |
| | | | | |
|
PR:000060427 |
breast cancer type 2 susceptibility protein sequence variant E1120* (human) | | | | | |
| | | | | |
|
PR:000063272 |
breast cancer type 2 susceptibility protein sequence variant E1276* (human) | | | | | |
| | | | | |
|
PR:000063067 |
breast cancer type 2 susceptibility protein sequence variant E1285* (human) | | | | | |
| | | | | |
|
PR:000064098 |
breast cancer type 2 susceptibility protein sequence variant E1441* (human) | | | | | |
| | | | | |
|
PR:000061354 |
breast cancer type 2 susceptibility protein sequence variant E1493* (human) | | | | | |
| | | | | |
|
PR:000061047 |
breast cancer type 2 susceptibility protein sequence variant E1514* (human) | | | | | |
| | | | | |
|
PR:000063561 |
breast cancer type 2 susceptibility protein sequence variant E1518* (human) | | | | | |
| | | | | |
|
PR:000063667 |
breast cancer type 2 susceptibility protein sequence variant E1555* (human) | | | | | |
| | | | | |
|
PR:000063320 |
breast cancer type 2 susceptibility protein sequence variant E1581* (human) | | | | | |
| | | | | |
|
PR:000062045 |
breast cancer type 2 susceptibility protein sequence variant E1593* (human) | | | | | |
| | | | | |
|
PR:000062761 |
breast cancer type 2 susceptibility protein sequence variant E1646* (human) | | | | | |
| | | | | |
|
PR:000061436 |
breast cancer type 2 susceptibility protein sequence variant E1688* (human) | | | | | |
| | | | | |
|
PR:000061921 |
breast cancer type 2 susceptibility protein sequence variant E1717* (human) | | | | | |
| | | | | |
|
PR:000061964 |
breast cancer type 2 susceptibility protein sequence variant E1812* (human) | | | | | |
| | | | | |
|
PR:000064420 |
breast cancer type 2 susceptibility protein sequence variant E187* (human) | | | | | |
| | | | | |
|
PR:000060549 |
breast cancer type 2 susceptibility protein sequence variant E2028* (human) | | | | | |
| | | | | |
|
PR:000063385 |
breast cancer type 2 susceptibility protein sequence variant E2129* (human) | | | | | |
| | | | | |
|
PR:000061932 |
breast cancer type 2 susceptibility protein sequence variant E2474* (human) | | | | | |
| | | | | |
|
PR:000063404 |
breast cancer type 2 susceptibility protein sequence variant E2476* (human) | | | | | |
| | | | | |
|
PR:000064389 |
breast cancer type 2 susceptibility protein sequence variant E2571* (human) | | | | | |
| | | | | |
|
PR:000064088 |
breast cancer type 2 susceptibility protein sequence variant E2599* (human) | | | | | |
| | | | | |
|
PR:000061248 |
breast cancer type 2 susceptibility protein sequence variant E2663Q (human) | | | | | |
| | | | | |
|
PR:000063327 |
breast cancer type 2 susceptibility protein sequence variant E2663V (human) | | | | | |
| | | | | |
|
PR:000061057 |
breast cancer type 2 susceptibility protein sequence variant E2847* (human) | | | | | |
| | | | | |
|
PR:000062866 |
breast cancer type 2 susceptibility protein sequence variant E2863* (human) | | | | | |
| | | | | |
|
PR:000061413 |
breast cancer type 2 susceptibility protein sequence variant E2872* (human) | | | | | |
| | | | | |
|
PR:000060393 |
breast cancer type 2 susceptibility protein sequence variant E2906* (human) | | | | | |
| | | | | |
|
PR:000063289 |
breast cancer type 2 susceptibility protein sequence variant E294* (human) | | | | | |
| | | | | |
|
PR:000062546 |
breast cancer type 2 susceptibility protein sequence variant E2956* (human) | | | | | |
| | | | | |
|
PR:000063010 |
breast cancer type 2 susceptibility protein sequence variant E2959* (human) | | | | | |
| | | | | |
|
PR:000063759 |
breast cancer type 2 susceptibility protein sequence variant E305* (human) | | | | | |
| | | | | |
|
PR:000060466 |
breast cancer type 2 susceptibility protein sequence variant E3053* (human) | | | | | |
| | | | | |
|
PR:000063240 |
breast cancer type 2 susceptibility protein sequence variant E3071* (human) | | | | | |
| | | | | |
|
PR:000062082 |
breast cancer type 2 susceptibility protein sequence variant E3111* (human) | | | | | |
| | | | | |
|
PR:000062124 |
breast cancer type 2 susceptibility protein sequence variant E409* (human) | | | | | |
| | | | | |
|
PR:000061267 |
breast cancer type 2 susceptibility protein sequence variant E475* (human) | | | | | |
| | | | | |
|
PR:000062133 |
breast cancer type 2 susceptibility protein sequence variant E510* (human) | | | | | |
| | | | | |
|
PR:000062635 |
breast cancer type 2 susceptibility protein sequence variant E654* (human) | | | | | |
| | | | | |
|
PR:000061209 |
breast cancer type 2 susceptibility protein sequence variant E808* (human) | | | | | |
| | | | | |
|
PR:000062820 |
breast cancer type 2 susceptibility protein sequence variant E826* (human) | | | | | |
| | | | | |
|
PR:000060516 |
breast cancer type 2 susceptibility protein sequence variant E865* (human) | | | | | |
| | | | | |
|
PR:000061914 |
breast cancer type 2 susceptibility protein sequence variant E866* (human) | | | | | |
| | | | | |
|
PR:000064128 |
breast cancer type 2 susceptibility protein sequence variant E880* (human) | | | | | |
| | | | | |
|
PR:000063540 |
breast cancer type 2 susceptibility protein sequence variant E897* (human) | | | | | |
| | | | | |
|
PR:000060571 |
breast cancer type 2 susceptibility protein sequence variant E97* (human) | | | | | |
| | | | | |
|
PR:000063225 |
breast cancer type 2 susceptibility protein sequence variant F1182* (human) | | | | | |
| | | | | |
|
PR:000063072 |
breast cancer type 2 susceptibility protein sequence variant G1006* (human) | | | | | |
| | | | | |
|
PR:000064169 |
breast cancer type 2 susceptibility protein sequence variant G106* (human) | | | | | |
| | | | | |
|
PR:000063713 |
breast cancer type 2 susceptibility protein sequence variant G1122* (human) | | | | | |
| | | | | |
|
PR:000060354 |
breast cancer type 2 susceptibility protein sequence variant G1529E (human) | | | | | |
| | | | | |
|
PR:000062990 |
breast cancer type 2 susceptibility protein sequence variant G1529R (human) | | | | | |
| | | | | |
|
PR:000062704 |
breast cancer type 2 susceptibility protein sequence variant G2281* (human) | | | | | |
| | | | | |
|
PR:000063222 |
breast cancer type 2 susceptibility protein sequence variant G2593* (human) | | | | | |
| | | | | |
|
PR:000063243 |
breast cancer type 2 susceptibility protein sequence variant G25R (human) | | | | | |
| | | | | |
|
PR:000062708 |
breast cancer type 2 susceptibility protein sequence variant G25V (human) | | | | | |
| | | | | |
|
PR:000063424 |
breast cancer type 2 susceptibility protein sequence variant G2748D (human) | | | | | |
| | | | | |
|
PR:000062147 |
breast cancer type 2 susceptibility protein sequence variant G2837* (human) | | | | | |
| | | | | |
|
PR:000063781 |
breast cancer type 2 susceptibility protein sequence variant G4* (human) | | | | | |
| | | | | |
|
PR:000064571 |
breast cancer type 2 susceptibility protein sequence variant G405* (human) | | | | | |
| | | | | |
|
PR:000063301 |
breast cancer type 2 susceptibility protein sequence variant G561* (human) | | | | | |
| | | | | |
|
PR:000061763 |
breast cancer type 2 susceptibility protein sequence variant G904* (human) | | | | | |
| | | | | |
|
PR:000060539 |
breast cancer type 2 susceptibility protein sequence variant G934* (human) | | | | | |
| | | | | |
|
PR:000063387 |
breast cancer type 2 susceptibility protein sequence variant G995* (human) | | | | | |
| | | | | |
|
PR:000061772 |
breast cancer type 2 susceptibility protein sequence variant I1258* (human) | | | | | |
| | | | | |
|
PR:000060956 |
breast cancer type 2 susceptibility protein sequence variant I2627F (human) | | | | | |
| | | | | |
|
PR:000061755 |
breast cancer type 2 susceptibility protein sequence variant K1082* (human) | | | | | |
| | | | | |
|
PR:000063737 |
breast cancer type 2 susceptibility protein sequence variant K1453* (human) | | | | | |
| | | | | |
|
PR:000061343 |
breast cancer type 2 susceptibility protein sequence variant K1515* (human) | | | | | |
| | | | | |
|
PR:000062063 |
breast cancer type 2 susceptibility protein sequence variant K1649* (human) | | | | | |
| | | | | |
|
PR:000064473 |
breast cancer type 2 susceptibility protein sequence variant K178* (human) | | | | | |
| | | | | |
|
PR:000060489 |
breast cancer type 2 susceptibility protein sequence variant K1860* (human) | | | | | |
| | | | | |
|
PR:000062834 |
breast cancer type 2 susceptibility protein sequence variant K1872* (human) | | | | | |
| | | | | |
|
PR:000061572 |
breast cancer type 2 susceptibility protein sequence variant K230* (human) | | | | | |
| | | | | |
|
PR:000061829 |
breast cancer type 2 susceptibility protein sequence variant K2392* (human) | | | | | |
| | | | | |
|
PR:000060829 |
breast cancer type 2 susceptibility protein sequence variant K2555* (human) | | | | | |
| | | | | |
|
PR:000062918 |
breast cancer type 2 susceptibility protein sequence variant K2570* (human) | | | | | |
| | | | | |
|
PR:000061622 |
breast cancer type 2 susceptibility protein sequence variant K3015* (human) | | | | | |
| | | | | |
|
PR:000064511 |
breast cancer type 2 susceptibility protein sequence variant K3032* (human) | | | | | |
| | | | | |
|
PR:000064081 |
breast cancer type 2 susceptibility protein sequence variant K467* (human) | | | | | |
| | | | | |
|
PR:000063389 |
breast cancer type 2 susceptibility protein sequence variant K604* (human) | | | | | |
| | | | | |
|
PR:000064320 |
breast cancer type 2 susceptibility protein sequence variant K944* (human) | | | | | |
| | | | | |
|
PR:000063657 |
breast cancer type 2 susceptibility protein sequence variant L105* (human) | | | | | |
| | | | | |
|
PR:000060692 |
breast cancer type 2 susceptibility protein sequence variant L1208* (human) | | | | | |
| | | | | |
|
PR:000060282 |
breast cancer type 2 susceptibility protein sequence variant L1740* (human) | | | | | |
| | | | | |
|
PR:000062484 |
breast cancer type 2 susceptibility protein sequence variant L1776* (human) | | | | | |
| | | | | |
|
PR:000063762 |
breast cancer type 2 susceptibility protein sequence variant L1952* (human) | | | | | |
| | | | | |
|
PR:000060421 |
breast cancer type 2 susceptibility protein sequence variant L2362* (human) | | | | | |
| | | | | |
|
PR:000062314 |
breast cancer type 2 susceptibility protein sequence variant L2375* (human) | | | | | |
| | | | | |
|
PR:000064380 |
breast cancer type 2 susceptibility protein sequence variant L2428* (human) | | | | | |
| | | | | |
|
PR:000062976 |
breast cancer type 2 susceptibility protein sequence variant L2696* (human) | | | | | |
| | | | | |
|
PR:000061442 |
breast cancer type 2 susceptibility protein sequence variant L2926* (human) | | | | | |
| | | | | |
|
PR:000063108 |
breast cancer type 2 susceptibility protein sequence variant L553* (human) | | | | | |
| | | | | |
|
PR:000060575 |
breast cancer type 2 susceptibility protein sequence variant L557* (human) | | | | | |
| | | | | |
|
PR:000062110 |
breast cancer type 2 susceptibility protein sequence variant L638* (human) | | | | | |
| | | | | |
|
PR:000064410 |
breast cancer type 2 susceptibility protein sequence variant L659* (human) | | | | | |
| | | | | |
|
PR:000061384 |
breast cancer type 2 susceptibility protein sequence variant M1300* (human) | | | | | |
| | | | | |
|
PR:000062340 |
breast cancer type 2 susceptibility protein sequence variant M2393* (human) | | | | | |
| | | | | |
|
PR:000062479 |
breast cancer type 2 susceptibility protein sequence variant M965* (human) | | | | | |
| | | | | |
|
PR:000061987 |
breast cancer type 2 susceptibility protein sequence variant Q1063* (human) | | | | | |
| | | | | |
|
PR:000063120 |
breast cancer type 2 susceptibility protein sequence variant Q1124* (human) | | | | | |
| | | | | |
|
PR:000061249 |
breast cancer type 2 susceptibility protein sequence variant Q1175* (human) | | | | | |
| | | | | |
|
PR:000062427 |
breast cancer type 2 susceptibility protein sequence variant Q1429* (human) | | | | | |
| | | | | |
|
PR:000061760 |
breast cancer type 2 susceptibility protein sequence variant Q1452* (human) | | | | | |
| | | | | |
|
PR:000063585 |
breast cancer type 2 susceptibility protein sequence variant Q1551* (human) | | | | | |
| | | | | |
|
PR:000060653 |
breast cancer type 2 susceptibility protein sequence variant Q1562* (human) | | | | | |
| | | | | |
|
PR:000063407 |
breast cancer type 2 susceptibility protein sequence variant Q1658* (human) | | | | | |
| | | | | |
|
PR:000062947 |
breast cancer type 2 susceptibility protein sequence variant Q1987* (human) | | | | | |
| | | | | |
|
PR:000060274 |
breast cancer type 2 susceptibility protein sequence variant Q1998* (human) | | | | | |
| | | | | |
|
PR:000062357 |
breast cancer type 2 susceptibility protein sequence variant Q2024* (human) | | | | | |
| | | | | |
|
PR:000063456 |
breast cancer type 2 susceptibility protein sequence variant Q2159* (human) | | | | | |
| | | | | |
|
PR:000063673 |
breast cancer type 2 susceptibility protein sequence variant Q2354* (human) | | | | | |
| | | | | |
|
PR:000064423 |
breast cancer type 2 susceptibility protein sequence variant Q2731* (human) | | | | | |
| | | | | |
|
PR:000063961 |
breast cancer type 2 susceptibility protein sequence variant Q2749* (human) | | | | | |
| | | | | |
|
PR:000060568 |
breast cancer type 2 susceptibility protein sequence variant Q2823* (human) | | | | | |
| | | | | |
|
PR:000062861 |
breast cancer type 2 susceptibility protein sequence variant Q2870* (human) | | | | | |
| | | | | |
|
PR:000064047 |
breast cancer type 2 susceptibility protein sequence variant Q3026* (human) | | | | | |
| | | | | |
|
PR:000062574 |
breast cancer type 2 susceptibility protein sequence variant Q3036* (human) | | | | | |
| | | | | |
|
PR:000060333 |
breast cancer type 2 susceptibility protein sequence variant Q3066* (human) | | | | | |
| | | | | |
|
PR:000062501 |
breast cancer type 2 susceptibility protein sequence variant Q373* (human) | | | | | |
| | | | | |
|
PR:000060946 |
breast cancer type 2 susceptibility protein sequence variant Q499* (human) | | | | | |
| | | | | |
|
PR:000061434 |
breast cancer type 2 susceptibility protein sequence variant Q609* (human) | | | | | |
| | | | | |
|
PR:000061418 |
breast cancer type 2 susceptibility protein sequence variant Q73* (human) | | | | | |
| | | | | |
|
PR:000062240 |
breast cancer type 2 susceptibility protein sequence variant Q754* (human) | | | | | |
| | | | | |
|
PR:000061616 |
breast cancer type 2 susceptibility protein sequence variant Q893* (human) | | | | | |
| | | | | |
|
PR:000063497 |
breast cancer type 2 susceptibility protein sequence variant R2318* (human) | | | | | |
| | | | | |
|
PR:000063290 |
breast cancer type 2 susceptibility protein sequence variant R2401* (human) | | | | | |
| | | | | |
|
PR:000063256 |
breast cancer type 2 susceptibility protein sequence variant R2520* (human) | | | | | |
| | | | | |
|
PR:000062558 |
breast cancer type 2 susceptibility protein sequence variant R2625* (human) | | | | | |
| | | | | |
|
PR:000061909 |
breast cancer type 2 susceptibility protein sequence variant R2659T (human) | | | | | |
| | | | | |
|
PR:000063206 |
breast cancer type 2 susceptibility protein sequence variant R3128* (human) | | | | | |
| | | | | |
|
PR:000060984 |
breast cancer type 2 susceptibility protein sequence variant S1013* (human) | | | | | |
| | | | | |
|
PR:000061227 |
breast cancer type 2 susceptibility protein sequence variant S1064* (human) | | | | | |
| | | | | |
|
PR:000061793 |
breast cancer type 2 susceptibility protein sequence variant S1099* (human) | | | | | |
| | | | | |
|
PR:000062573 |
breast cancer type 2 susceptibility protein sequence variant S1271* (human) | | | | | |
| | | | | |
|
PR:000064536 |
breast cancer type 2 susceptibility protein sequence variant S1385* (human) | | | | | |
| | | | | |
|
PR:000060887 |
breast cancer type 2 susceptibility protein sequence variant S1442* (human) | | | | | |
| | | | | |
|
PR:000063901 |
breast cancer type 2 susceptibility protein sequence variant S1630* (human) | | | | | |
| | | | | |
|
PR:000061081 |
breast cancer type 2 susceptibility protein sequence variant S1720* (human) | | | | | |
| | | | | |
|
PR:000063952 |
breast cancer type 2 susceptibility protein sequence variant S1882* (human) | | | | | |
| | | | | |
|
PR:000060285 |
breast cancer type 2 susceptibility protein sequence variant S1968* (human) | | | | | |
| | | | | |
|
PR:000061675 |
breast cancer type 2 susceptibility protein sequence variant S2052* (human) | | | | | |
| | | | | |
|
PR:000060654 |
breast cancer type 2 susceptibility protein sequence variant S2095* (human) | | | | | |
| | | | | |
|
PR:000061867 |
breast cancer type 2 susceptibility protein sequence variant S2372* (human) | | | | | |
| | | | | |
|
PR:000063042 |
breast cancer type 2 susceptibility protein sequence variant S2695* (human) | | | | | |
| | | | | |
|
PR:000063123 |
breast cancer type 2 susceptibility protein sequence variant S2835* (human) | | | | | |
| | | | | |
|
PR:000063689 |
breast cancer type 2 susceptibility protein sequence variant S2978* (human) | | | | | |
| | | | | |
|
PR:000060602 |
breast cancer type 2 susceptibility protein sequence variant S2994* (human) | | | | | |
| | | | | |
|
PR:000061329 |
breast cancer type 2 susceptibility protein sequence variant S3231* (human) | | | | | |
| | | | | |
|
PR:000060390 |
breast cancer type 2 susceptibility protein sequence variant S3245* (human) | | | | | |
| | | | | |
|
PR:000063079 |
breast cancer type 2 susceptibility protein sequence variant S3291A (human) | | | | | |
| | | | | |
|
PR:000062152 |
breast cancer type 2 susceptibility protein sequence variant S353* (human) | | | | | |
| | | | | |
|
PR:000061260 |
breast cancer type 2 susceptibility protein sequence variant S450* (human) | | | | | |
| | | | | |
|
PR:000061243 |
breast cancer type 2 susceptibility protein sequence variant S611* (human) | | | | | |
| | | | | |
|
PR:000064558 |
breast cancer type 2 susceptibility protein sequence variant S648* (human) | | | | | |
| | | | | |
|
PR:000062904 |
breast cancer type 2 susceptibility protein sequence variant S744* (human) | | | | | |
| | | | | |
|
PR:000061439 |
breast cancer type 2 susceptibility protein sequence variant S76* (human) | | | | | |
| | | | | |
|
PR:000060858 |
breast cancer type 2 susceptibility protein sequence variant S871* (human) | | | | | |
| | | | | |
|
PR:000062756 |
breast cancer type 2 susceptibility protein sequence variant T2722I (human) | | | | | |
| | | | | |
|
PR:000062206 |
breast cancer type 2 susceptibility protein sequence variant T2722R (human) | | | | | |
| | | | | |
|
PR:000064172 |
breast cancer type 2 susceptibility protein sequence variant V1862* (human) | | | | | |
| | | | | |
|
PR:000061844 |
breast cancer type 2 susceptibility protein sequence variant V323* (human) | | | | | |
| | | | | |
|
PR:000062320 |
breast cancer type 2 susceptibility protein sequence variant W2586* (human) | | | | | |
| | | | | |
|
PR:000060891 |
breast cancer type 2 susceptibility protein sequence variant W2626C (human) | | | | | |
| | | | | |
|
PR:000063448 |
breast cancer type 2 susceptibility protein sequence variant W2626L (human) | | | | | |
| | | | | |
|
PR:000061049 |
breast cancer type 2 susceptibility protein sequence variant W2970* (human) | | | | | |
| | | | | |
|
PR:000061347 |
breast cancer type 2 susceptibility protein sequence variant W31* (human) | | | | | |
| | | | | |
|
PR:000064549 |
breast cancer type 2 susceptibility protein sequence variant W31C (human) | | | | | |
| | | | | |
|
PR:000063262 |
breast cancer type 2 susceptibility protein sequence variant W31R (human) | | | | | |
| | | | | |
|
PR:000061074 |
breast cancer type 2 susceptibility protein sequence variant Y1714* (human) | | | | | |
| | | | | |
|
PR:000060343 |
breast cancer type 2 susceptibility protein sequence variant Y1762* (human) | | | | | |
| | | | | |
|
PR:000062987 |
breast cancer type 2 susceptibility protein sequence variant Y1894* (human) | | | | | |
| | | | | |
|
PR:000062900 |
breast cancer type 2 susceptibility protein sequence variant Y2884* (human) | | | | | |
| | | | | |
|
PR:000061926 |
breast cancer type 2 susceptibility protein sequence variant Y2977* (human) | | | | | |
| | | | | |
|
PR:000061491 |
breast cancer type 2 susceptibility protein sequence variant Y2997* (human) | | | | | |
| | | | | |
|
PR:000060677 |
breast cancer type 2 susceptibility protein sequence variant Y3006* (human) | | | | | |
| | | | | |
|
PR:000060630 |
breast cancer type 2 susceptibility protein sequence variant Y803* (human) | | | | | |
| | | | | |
|
PR:000045545 |
breast cancer type 2 susceptibility protein unphosphorylated 2 (human) | | | | | |
| |
| |
| | | | |
|
PR:P51587 |
breast cancer type 2 susceptibility protein (human) | | | | | |
| | | | | |
|
PR:000078580 |
breast cancer type 2 susceptibility protein cysteinylated 1 (human) | | | | | |
| | | | | |
|
PR:000066432 |
breast cancer type 2 susceptibility protein deaminated 1 (human) | | | | | |
| | | | | |
|
PR:000066492 |
breast cancer type 2 susceptibility protein deaminated 2 (human) | | | | | |
| | | | | |
|
PR:000072027 |
breast cancer type 2 susceptibility protein deaminated 3 (human) | | | | | |
| | | | | |
|
PR:000073005 |
breast cancer type 2 susceptibility protein deaminated 4 (human) | | | | | |
| | | | | |
|
PR:000067955 |
breast cancer type 2 susceptibility protein methylated 1 (human) | | | | | |
| | | | | |
|
PR:000070934 |
breast cancer type 2 susceptibility protein methylated 2 (human) | | | | | |
| | | | | |
|
PR:000072752 |
breast cancer type 2 susceptibility protein methylated 3 (human) | | | | | |
| | | | | |
|
PR:000080574 |
breast cancer type 2 susceptibility protein methylated 4 (human) | | | | | |
| | | | | |
|
PR:000035486 |
breast cancer type 2 susceptibility protein phosphorylated 1 (human) | | | | | |
| | | | | |
|
PR:000045544 |
breast cancer type 2 susceptibility protein phosphorylated 2 (human) | | | | | |
| | | | | |
|
PR:000045817 |
breast cancer type 2 susceptibility protein phosphorylated 3 (human) | | | | | |
| | | | | |
|
PR:000075561 |
breast cancer type 2 susceptibility protein phosphorylated 4 (human) | | | | | |
| | | | | |
|
PR:000061485 |
breast cancer type 2 susceptibility protein sequence variant C1200* (human) | | | | | |
| | | | | |
|
PR:000060791 |
breast cancer type 2 susceptibility protein sequence variant C2422* (human) | | | | | |
| | | | | |
|
PR:000060763 |
breast cancer type 2 susceptibility protein sequence variant C711* (human) | | | | | |
| | | | | |
|
PR:000064582 |
breast cancer type 2 susceptibility protein sequence variant D2723G (human) | | | | | |
| | | | | |
|
PR:000062322 |
breast cancer type 2 susceptibility protein sequence variant D2723H (human) | | | | | |
| | | | | |
|
PR:000063423 |
breast cancer type 2 susceptibility protein sequence variant E1113* (human) | | | | | |
| | | | | |
|
PR:000060427 |
breast cancer type 2 susceptibility protein sequence variant E1120* (human) | | | | | |
| | | | | |
|
PR:000063272 |
breast cancer type 2 susceptibility protein sequence variant E1276* (human) | | | | | |
| | | | | |
|
PR:000063067 |
breast cancer type 2 susceptibility protein sequence variant E1285* (human) | | | | | |
| | | | | |
|
PR:000064098 |
breast cancer type 2 susceptibility protein sequence variant E1441* (human) | | | | | |
| | | | | |
|
PR:000061354 |
breast cancer type 2 susceptibility protein sequence variant E1493* (human) | | | | | |
| | | | | |
|
PR:000061047 |
breast cancer type 2 susceptibility protein sequence variant E1514* (human) | | | | | |
| | | | | |
|
PR:000063561 |
breast cancer type 2 susceptibility protein sequence variant E1518* (human) | | | | | |
| | | | | |
|
PR:000063667 |
breast cancer type 2 susceptibility protein sequence variant E1555* (human) | | | | | |
| | | | | |
|
PR:000063320 |
breast cancer type 2 susceptibility protein sequence variant E1581* (human) | | | | | |
| | | | | |
|
PR:000062045 |
breast cancer type 2 susceptibility protein sequence variant E1593* (human) | | | | | |
| | | | | |
|
PR:000062761 |
breast cancer type 2 susceptibility protein sequence variant E1646* (human) | | | | | |
| | | | | |
|
PR:000061436 |
breast cancer type 2 susceptibility protein sequence variant E1688* (human) | | | | | |
| | | | | |
|
PR:000061921 |
breast cancer type 2 susceptibility protein sequence variant E1717* (human) | | | | | |
| | | | | |
|
PR:000061964 |
breast cancer type 2 susceptibility protein sequence variant E1812* (human) | | | | | |
| | | | | |
|
PR:000064420 |
breast cancer type 2 susceptibility protein sequence variant E187* (human) | | | | | |
| | | | | |
|
PR:000060549 |
breast cancer type 2 susceptibility protein sequence variant E2028* (human) | | | | | |
| | | | | |
|
PR:000063385 |
breast cancer type 2 susceptibility protein sequence variant E2129* (human) | | | | | |
| | | | | |
|
PR:000061932 |
breast cancer type 2 susceptibility protein sequence variant E2474* (human) | | | | | |
| | | | | |
|
PR:000063404 |
breast cancer type 2 susceptibility protein sequence variant E2476* (human) | | | | | |
| | | | | |
|
PR:000064389 |
breast cancer type 2 susceptibility protein sequence variant E2571* (human) | | | | | |
| | | | | |
|
PR:000064088 |
breast cancer type 2 susceptibility protein sequence variant E2599* (human) | | | | | |
| | | | | |
|
PR:000061248 |
breast cancer type 2 susceptibility protein sequence variant E2663Q (human) | | | | | |
| | | | | |
|
PR:000063327 |
breast cancer type 2 susceptibility protein sequence variant E2663V (human) | | | | | |
| | | | | |
|
PR:000061057 |
breast cancer type 2 susceptibility protein sequence variant E2847* (human) | | | | | |
| | | | | |
|
PR:000062866 |
breast cancer type 2 susceptibility protein sequence variant E2863* (human) | | | | | |
| | | | | |
|
PR:000061413 |
breast cancer type 2 susceptibility protein sequence variant E2872* (human) | | | | | |
| | | | | |
|
PR:000060393 |
breast cancer type 2 susceptibility protein sequence variant E2906* (human) | | | | | |
| | | | | |
|
PR:000063289 |
breast cancer type 2 susceptibility protein sequence variant E294* (human) | | | | | |
| | | | | |
|
PR:000062546 |
breast cancer type 2 susceptibility protein sequence variant E2956* (human) | | | | | |
| | | | | |
|
PR:000063010 |
breast cancer type 2 susceptibility protein sequence variant E2959* (human) | | | | | |
| | | | | |
|
PR:000063759 |
breast cancer type 2 susceptibility protein sequence variant E305* (human) | | | | | |
| | | | | |
|
PR:000060466 |
breast cancer type 2 susceptibility protein sequence variant E3053* (human) | | | | | |
| | | | | |
|
PR:000063240 |
breast cancer type 2 susceptibility protein sequence variant E3071* (human) | | | | | |
| | | | | |
|
PR:000062082 |
breast cancer type 2 susceptibility protein sequence variant E3111* (human) | | | | | |
| | | | | |
|
PR:000062124 |
breast cancer type 2 susceptibility protein sequence variant E409* (human) | | | | | |
| | | | | |
|
PR:000061267 |
breast cancer type 2 susceptibility protein sequence variant E475* (human) | | | | | |
| | | | | |
|
PR:000062133 |
breast cancer type 2 susceptibility protein sequence variant E510* (human) | | | | | |
| | | | | |
|
PR:000062635 |
breast cancer type 2 susceptibility protein sequence variant E654* (human) | | | | | |
| | | | | |
|
PR:000061209 |
breast cancer type 2 susceptibility protein sequence variant E808* (human) | | | | | |
| | | | | |
|
PR:000062820 |
breast cancer type 2 susceptibility protein sequence variant E826* (human) | | | | | |
| | | | | |
|
PR:000060516 |
breast cancer type 2 susceptibility protein sequence variant E865* (human) | | | | | |
| | | | | |
|
PR:000061914 |
breast cancer type 2 susceptibility protein sequence variant E866* (human) | | | | | |
| | | | | |
|
PR:000064128 |
breast cancer type 2 susceptibility protein sequence variant E880* (human) | | | | | |
| | | | | |
|
PR:000063540 |
breast cancer type 2 susceptibility protein sequence variant E897* (human) | | | | | |
| | | | | |
|
PR:000060571 |
breast cancer type 2 susceptibility protein sequence variant E97* (human) | | | | | |
| | | | | |
|
PR:000063225 |
breast cancer type 2 susceptibility protein sequence variant F1182* (human) | | | | | |
| | | | | |
|
PR:000063072 |
breast cancer type 2 susceptibility protein sequence variant G1006* (human) | | | | | |
| | | | | |
|
PR:000064169 |
breast cancer type 2 susceptibility protein sequence variant G106* (human) | | | | | |
| | | | | |
|
PR:000063713 |
breast cancer type 2 susceptibility protein sequence variant G1122* (human) | | | | | |
| | | | | |
|
PR:000060354 |
breast cancer type 2 susceptibility protein sequence variant G1529E (human) | | | | | |
| | | | | |
|
PR:000062990 |
breast cancer type 2 susceptibility protein sequence variant G1529R (human) | | | | | |
| | | | | |
|
PR:000062704 |
breast cancer type 2 susceptibility protein sequence variant G2281* (human) | | | | | |
| | | | | |
|
PR:000063222 |
breast cancer type 2 susceptibility protein sequence variant G2593* (human) | | | | | |
| | | | | |
|
PR:000063243 |
breast cancer type 2 susceptibility protein sequence variant G25R (human) | | | | | |
| | | | | |
|
PR:000062708 |
breast cancer type 2 susceptibility protein sequence variant G25V (human) | | | | | |
| | | | | |
|
PR:000063424 |
breast cancer type 2 susceptibility protein sequence variant G2748D (human) | | | | | |
| | | | | |
|
PR:000062147 |
breast cancer type 2 susceptibility protein sequence variant G2837* (human) | | | | | |
| | | | | |
|
PR:000063781 |
breast cancer type 2 susceptibility protein sequence variant G4* (human) | | | | | |
| | | | | |
|
PR:000064571 |
breast cancer type 2 susceptibility protein sequence variant G405* (human) | | | | | |
| | | | | |
|
PR:000063301 |
breast cancer type 2 susceptibility protein sequence variant G561* (human) | | | | | |
| | | | | |
|
PR:000061763 |
breast cancer type 2 susceptibility protein sequence variant G904* (human) | | | | | |
| | | | | |
|
PR:000060539 |
breast cancer type 2 susceptibility protein sequence variant G934* (human) | | | | | |
| | | | | |
|
PR:000063387 |
breast cancer type 2 susceptibility protein sequence variant G995* (human) | | | | | |
| | | | | |
|
PR:000061772 |
breast cancer type 2 susceptibility protein sequence variant I1258* (human) | | | | | |
| | | | | |
|
PR:000060956 |
breast cancer type 2 susceptibility protein sequence variant I2627F (human) | | | | | |
| | | | | |
|
PR:000061755 |
breast cancer type 2 susceptibility protein sequence variant K1082* (human) | | | | | |
| | | | | |
|
PR:000063737 |
breast cancer type 2 susceptibility protein sequence variant K1453* (human) | | | | | |
| | | | | |
|
PR:000061343 |
breast cancer type 2 susceptibility protein sequence variant K1515* (human) | | | | | |
| | | | | |
|
PR:000062063 |
breast cancer type 2 susceptibility protein sequence variant K1649* (human) | | | | | |
| | | | | |
|
PR:000064473 |
breast cancer type 2 susceptibility protein sequence variant K178* (human) | | | | | |
| | | | | |
|
PR:000060489 |
breast cancer type 2 susceptibility protein sequence variant K1860* (human) | | | | | |
| | | | | |
|
PR:000062834 |
breast cancer type 2 susceptibility protein sequence variant K1872* (human) | | | | | |
| | | | | |
|
PR:000061572 |
breast cancer type 2 susceptibility protein sequence variant K230* (human) | | | | | |
| | | | | |
|
PR:000061829 |
breast cancer type 2 susceptibility protein sequence variant K2392* (human) | | | | | |
| | | | | |
|
PR:000060829 |
breast cancer type 2 susceptibility protein sequence variant K2555* (human) | | | | | |
| | | | | |
|
PR:000062918 |
breast cancer type 2 susceptibility protein sequence variant K2570* (human) | | | | | |
| | | | | |
|
PR:000061622 |
breast cancer type 2 susceptibility protein sequence variant K3015* (human) | | | | | |
| | | | | |
|
PR:000064511 |
breast cancer type 2 susceptibility protein sequence variant K3032* (human) | | | | | |
| | | | | |
|
PR:000064081 |
breast cancer type 2 susceptibility protein sequence variant K467* (human) | | | | | |
| | | | | |
|
PR:000063389 |
breast cancer type 2 susceptibility protein sequence variant K604* (human) | | | | | |
| | | | | |
|
PR:000064320 |
breast cancer type 2 susceptibility protein sequence variant K944* (human) | | | | | |
| | | | | |
|
PR:000063657 |
breast cancer type 2 susceptibility protein sequence variant L105* (human) | | | | | |
| | | | | |
|
PR:000060692 |
breast cancer type 2 susceptibility protein sequence variant L1208* (human) | | | | | |
| | | | | |
|
PR:000060282 |
breast cancer type 2 susceptibility protein sequence variant L1740* (human) | | | | | |
| | | | | |
|
PR:000062484 |
breast cancer type 2 susceptibility protein sequence variant L1776* (human) | | | | | |
| | | | | |
|
PR:000063762 |
breast cancer type 2 susceptibility protein sequence variant L1952* (human) | | | | | |
| | | | | |
|
PR:000060421 |
breast cancer type 2 susceptibility protein sequence variant L2362* (human) | | | | | |
| | | | | |
|
PR:000062314 |
breast cancer type 2 susceptibility protein sequence variant L2375* (human) | | | | | |
| | | | | |
|
PR:000064380 |
breast cancer type 2 susceptibility protein sequence variant L2428* (human) | | | | | |
| | | | | |
|
PR:000062976 |
breast cancer type 2 susceptibility protein sequence variant L2696* (human) | | | | | |
| | | | | |
|
PR:000061442 |
breast cancer type 2 susceptibility protein sequence variant L2926* (human) | | | | | |
| | | | | |
|
PR:000063108 |
breast cancer type 2 susceptibility protein sequence variant L553* (human) | | | | | |
| | | | | |
|
PR:000060575 |
breast cancer type 2 susceptibility protein sequence variant L557* (human) | | | | | |
| | | | | |
|
PR:000062110 |
breast cancer type 2 susceptibility protein sequence variant L638* (human) | | | | | |
| | | | | |
|
PR:000064410 |
breast cancer type 2 susceptibility protein sequence variant L659* (human) | | | | | |
| | | | | |
|
PR:000061384 |
breast cancer type 2 susceptibility protein sequence variant M1300* (human) | | | | | |
| | | | | |
|
PR:000062340 |
breast cancer type 2 susceptibility protein sequence variant M2393* (human) | | | | | |
| | | | | |
|
PR:000062479 |
breast cancer type 2 susceptibility protein sequence variant M965* (human) | | | | | |
| | | | | |
|
PR:000061987 |
breast cancer type 2 susceptibility protein sequence variant Q1063* (human) | | | | | |
| | | | | |
|
PR:000063120 |
breast cancer type 2 susceptibility protein sequence variant Q1124* (human) | | | | | |
| | | | | |
|
PR:000061249 |
breast cancer type 2 susceptibility protein sequence variant Q1175* (human) | | | | | |
| | | | | |
|
PR:000062427 |
breast cancer type 2 susceptibility protein sequence variant Q1429* (human) | | | | | |
| | | | | |
|
PR:000061760 |
breast cancer type 2 susceptibility protein sequence variant Q1452* (human) | | | | | |
| | | | | |
|
PR:000063585 |
breast cancer type 2 susceptibility protein sequence variant Q1551* (human) | | | | | |
| | | | | |
|
PR:000060653 |
breast cancer type 2 susceptibility protein sequence variant Q1562* (human) | | | | | |
| | | | | |
|
PR:000063407 |
breast cancer type 2 susceptibility protein sequence variant Q1658* (human) | | | | | |
| | | | | |
|
PR:000062947 |
breast cancer type 2 susceptibility protein sequence variant Q1987* (human) | | | | | |
| | | | | |
|
PR:000060274 |
breast cancer type 2 susceptibility protein sequence variant Q1998* (human) | | | | | |
| | | | | |
|
PR:000062357 |
breast cancer type 2 susceptibility protein sequence variant Q2024* (human) | | | | | |
| | | | | |
|
PR:000063456 |
breast cancer type 2 susceptibility protein sequence variant Q2159* (human) | | | | | |
| | | | | |
|
PR:000063673 |
breast cancer type 2 susceptibility protein sequence variant Q2354* (human) | | | | | |
| | | | | |
|
PR:000064423 |
breast cancer type 2 susceptibility protein sequence variant Q2731* (human) | | | | | |
| | | | | |
|
PR:000063961 |
breast cancer type 2 susceptibility protein sequence variant Q2749* (human) | | | | | |
| | | | | |
|
PR:000060568 |
breast cancer type 2 susceptibility protein sequence variant Q2823* (human) | | | | | |
| | | | | |
|
PR:000062861 |
breast cancer type 2 susceptibility protein sequence variant Q2870* (human) | | | | | |
| | | | | |
|
PR:000064047 |
breast cancer type 2 susceptibility protein sequence variant Q3026* (human) | | | | | |
| | | | | |
|
PR:000062574 |
breast cancer type 2 susceptibility protein sequence variant Q3036* (human) | | | | | |
| | | | | |
|
PR:000060333 |
breast cancer type 2 susceptibility protein sequence variant Q3066* (human) | | | | | |
| | | | | |
|
PR:000062501 |
breast cancer type 2 susceptibility protein sequence variant Q373* (human) | | | | | |
| | | | | |
|
PR:000060946 |
breast cancer type 2 susceptibility protein sequence variant Q499* (human) | | | | | |
| | | | | |
|
PR:000061434 |
breast cancer type 2 susceptibility protein sequence variant Q609* (human) | | | | | |
| | | | | |
|
PR:000061418 |
breast cancer type 2 susceptibility protein sequence variant Q73* (human) | | | | | |
| | | | | |
|
PR:000062240 |
breast cancer type 2 susceptibility protein sequence variant Q754* (human) | | | | | |
| | | | | |
|
PR:000061616 |
breast cancer type 2 susceptibility protein sequence variant Q893* (human) | | | | | |
| | | | | |
|
PR:000063497 |
breast cancer type 2 susceptibility protein sequence variant R2318* (human) | | | | | |
| | | | | |
|
PR:000063290 |
breast cancer type 2 susceptibility protein sequence variant R2401* (human) | | | | | |
| | | | | |
|
PR:000063256 |
breast cancer type 2 susceptibility protein sequence variant R2520* (human) | | | | | |
| | | | | |
|
PR:000062558 |
breast cancer type 2 susceptibility protein sequence variant R2625* (human) | | | | | |
| | | | | |
|
PR:000061909 |
breast cancer type 2 susceptibility protein sequence variant R2659T (human) | | | | | |
| | | | | |
|
PR:000063206 |
breast cancer type 2 susceptibility protein sequence variant R3128* (human) | | | | | |
| | | | | |
|
PR:000060984 |
breast cancer type 2 susceptibility protein sequence variant S1013* (human) | | | | | |
| | | | | |
|
PR:000061227 |
breast cancer type 2 susceptibility protein sequence variant S1064* (human) | | | | | |
| | | | | |
|
PR:000061793 |
breast cancer type 2 susceptibility protein sequence variant S1099* (human) | | | | | |
| | | | | |
|
PR:000062573 |
breast cancer type 2 susceptibility protein sequence variant S1271* (human) | | | | | |
| | | | | |
|
PR:000064536 |
breast cancer type 2 susceptibility protein sequence variant S1385* (human) | | | | | |
| | | | | |
|
PR:000060887 |
breast cancer type 2 susceptibility protein sequence variant S1442* (human) | | | | | |
| | | | | |
|
PR:000063901 |
breast cancer type 2 susceptibility protein sequence variant S1630* (human) | | | | | |
| | | | | |
|
PR:000061081 |
breast cancer type 2 susceptibility protein sequence variant S1720* (human) | | | | | |
| | | | | |
|
PR:000063952 |
breast cancer type 2 susceptibility protein sequence variant S1882* (human) | | | | | |
| | | | | |
|
PR:000060285 |
breast cancer type 2 susceptibility protein sequence variant S1968* (human) | | | | | |
| | | | | |
|
PR:000061675 |
breast cancer type 2 susceptibility protein sequence variant S2052* (human) | | | | | |
| | | | | |
|
PR:000060654 |
breast cancer type 2 susceptibility protein sequence variant S2095* (human) | | | | | |
| | | | | |
|
PR:000061867 |
breast cancer type 2 susceptibility protein sequence variant S2372* (human) | | | | | |
| | | | | |
|
PR:000063042 |
breast cancer type 2 susceptibility protein sequence variant S2695* (human) | | | | | |
| | | | | |
|
PR:000063123 |
breast cancer type 2 susceptibility protein sequence variant S2835* (human) | | | | | |
| | | | | |
|
PR:000063689 |
breast cancer type 2 susceptibility protein sequence variant S2978* (human) | | | | | |
| | | | | |
|
PR:000060602 |
breast cancer type 2 susceptibility protein sequence variant S2994* (human) | | | | | |
| | | | | |
|
PR:000061329 |
breast cancer type 2 susceptibility protein sequence variant S3231* (human) | | | | | |
| | | | | |
|
PR:000060390 |
breast cancer type 2 susceptibility protein sequence variant S3245* (human) | | | | | |
| | | | | |
|
PR:000063079 |
breast cancer type 2 susceptibility protein sequence variant S3291A (human) | | | | | |
| | | | | |
|
PR:000062152 |
breast cancer type 2 susceptibility protein sequence variant S353* (human) | | | | | |
| | | | | |
|
PR:000061260 |
breast cancer type 2 susceptibility protein sequence variant S450* (human) | | | | | |
| | | | | |
|
PR:000061243 |
breast cancer type 2 susceptibility protein sequence variant S611* (human) | | | | | |
| | | | | |
|
PR:000064558 |
breast cancer type 2 susceptibility protein sequence variant S648* (human) | | | | | |
| | | | | |
|
PR:000062904 |
breast cancer type 2 susceptibility protein sequence variant S744* (human) | | | | | |
| | | | | |
|
PR:000061439 |
breast cancer type 2 susceptibility protein sequence variant S76* (human) | | | | | |
| | | | | |
|
PR:000060858 |
breast cancer type 2 susceptibility protein sequence variant S871* (human) | | | | | |
| | | | | |
|
PR:000062756 |
breast cancer type 2 susceptibility protein sequence variant T2722I (human) | | | | | |
| | | | | |
|
PR:000062206 |
breast cancer type 2 susceptibility protein sequence variant T2722R (human) | | | | | |
| | | | | |
|
PR:000064172 |
breast cancer type 2 susceptibility protein sequence variant V1862* (human) | | | | | |
| | | | | |
|
PR:000061844 |
breast cancer type 2 susceptibility protein sequence variant V323* (human) | | | | | |
| | | | | |
|
PR:000062320 |
breast cancer type 2 susceptibility protein sequence variant W2586* (human) | | | | | |
| | | | | |
|
PR:000060891 |
breast cancer type 2 susceptibility protein sequence variant W2626C (human) | | | | | |
| | | | | |
|
PR:000063448 |
breast cancer type 2 susceptibility protein sequence variant W2626L (human) | | | | | |
| | | | | |
|
PR:000061049 |
breast cancer type 2 susceptibility protein sequence variant W2970* (human) | | | | | |
| | | | | |
|
PR:000061347 |
breast cancer type 2 susceptibility protein sequence variant W31* (human) | | | | | |
| | | | | |
|
PR:000064549 |
breast cancer type 2 susceptibility protein sequence variant W31C (human) | | | | | |
| | | | | |
|
PR:000063262 |
breast cancer type 2 susceptibility protein sequence variant W31R (human) | | | | | |
| | | | | |
|
PR:000061074 |
breast cancer type 2 susceptibility protein sequence variant Y1714* (human) | | | | | |
| | | | | |
|
PR:000060343 |
breast cancer type 2 susceptibility protein sequence variant Y1762* (human) | | | | | |
| | | | | |
|
PR:000062987 |
breast cancer type 2 susceptibility protein sequence variant Y1894* (human) | | | | | |
| | | | | |
|
PR:000062900 |
breast cancer type 2 susceptibility protein sequence variant Y2884* (human) | | | | | |
| | | | | |
|
PR:000061926 |
breast cancer type 2 susceptibility protein sequence variant Y2977* (human) | | | | | |
| | | | | |
|
PR:000061491 |
breast cancer type 2 susceptibility protein sequence variant Y2997* (human) | | | | | |
| | | | | |
|
PR:000060677 |
breast cancer type 2 susceptibility protein sequence variant Y3006* (human) | | | | | |
| | | | | |
|
PR:000060630 |
breast cancer type 2 susceptibility protein sequence variant Y803* (human) | | | | | |
| | | | | |
|
PR:000045545 |
breast cancer type 2 susceptibility protein unphosphorylated 2 (human) | | | | | |